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1. Introduction 
In a short span of few years, the possibility that the human body contains cells that can 
repair and regenerate damaged and diseased tissue has become a reality. Adult stem cells 
have been isolated from numerous adult tissues, umbilical cord, and other non-embryonic 
sources, and have demonstrated a surprising ability for transformation into other tissue and 
cell types and for the repair of damaged tissues. 
 
(Image: Hematopoiesis_ (human) _diagram.png by A. Rad) 
Figure 1. Hematopoiesis in Bone Marrow 
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In the 1950s, researchers discovered that the bone marrow contains stem cells i.e. 
hematopoietic stem cells (HSC) with the ability to self-renew and give rise to cell types in the 
blood and immune system (Figure1). Multipotent HSCs reside at the apex of hematopoietic 
hierarchy and they are connected to mature cells by a complex roadmap of progenitor 
intermediates. The HSC differentiate into two different kinds of progenitors viz. Common 
Myeloid Progenitors (CMP) and Common Lymphoid Progenitors (CLP), which further 
differentiate to various blood cells including platelets, granulocytes, lymphocytes and 
macrophages. As a result, bone marrow transplantation became the standard method of care 
for most hematopoietic malignancies whereby the HSCs were able to repopulate bone 
marrow after any kind of hematopoietic failure. A recent review by Doulatov et al [1] 
describes the knowledge gathered over the years on Hematopoiesis.  
Besides HSC, another stem cell population, the mesenchymal stem cells (MSC) was 
identified in the bone marrow about 40 years ago [2]. MSCs comprise of the adherent stem 
cell population with immune-modulatory properties. Besides bone marrow, MSCs can also 
be extracted from virtually all post-natal as well as extra-embryonic tissues such as amniotic 
membrane, placenta and umbilical cord. They can differentiate along multiple lineages and 
exhibit significant expansion capability in vitro. Co-transplantation with MSCs improves 
engraftment of HSCs after autologous intra-bone marrow transplantation [3]. MSCs are also 
considered useful as vehicles for emerging cell and gene therapies in the field of tissue 
engineering [4]. Recently it has been postulated that MSC provide the conducive 
microenvironment for HSCs and thus maintain the stemness and proliferation of HSCs and 
support HSC transplantation [3].  
2. Trans-differentiation of bone marrow stem cells 
Blood is one of the most highly regenerative tissues in our body with almost one trillion 
cells arising daily. Over the last decade several investigators have demonstrated that BM 
stem cells not only contribute to development of blood cells but also to the regeneration of 
various organs and tissues [5, 6]. MSC isolated from various sources can differentiate into 
diverse cell types, showing a unique ability to cross lineage borders (i.e. are able to 
differentiate towards ectoderm-, mesoderm- and endoderm-derived cell types) and do not 
express the major histocompatibility complex (MHC) class II Human Leukocyte Antigen 
(HLA-DR) antigens. This, together with their in vitro proliferative potential and their 
immunoregulatory properties, renders them extremely promising for regenerative medicine 
applications in several diseases [7]. 
These observations were mainly explained by the hypothesis that the BM stem cells are 
‘plastic’ and thus could dedifferentiate into various cell types of non-hematopoietic organs 
and tissues [8]. The possibility that HSC/MSC are plastic and able to trans-differentiate 
raised hope that HSC/MSC isolated from BM, mobilized into the peripheral blood (mPB) or 
cord blood (CB) could become a universal source of stem cells for tissue/ organ repair. This 
was supported by several demonstrations of the remarkable regenerative potential of HSC 
in animal models, for example after heart infarct [5], stroke [9], spinal cord injury [10], and 
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liver damage [11] and of MSC in skeletal regeneration [12], cardiac regeneration [13], 
diabetes [14] and osteogeneis imperfect [15]. The potential of adult stem cells also resulted in 
slow growth of research and funding restrictions on ES cells during President Bush regime 
in USA – based on the argument that destroying embryos to derive human ES cell lines was 
not essential, when better alternatives including adult stem cells are available for 
regenerative medicine (http://en.wikipedia.org/wiki/Stem_cell_controversy). However the 
excitement over plasticity of HSC reduced when their role in repair of damaged organs 
became controversial [16, 17].  
Several alternative mechanisms were proposed to explain the trans-differentiation of bone 
marrow stem cells [18] including (i) epigenetic changes i.e. factors present in the 
environment of damaged organs may induce epigenetic changes in the genes that regulate 
pluripotency of HSCs (ii) cell fusion during which infused HSCs may fuse with cells in 
damaged tissues and form heterokaryons which express markers of both donor and 
recipient cells (iii) paracrine effect i.e. HSCs are source of different trophic and angiopoietic 
factors that may promote tissue/organ repair (iv) microvesicles- dependent transfer of 
molecules like receptors, proteins and mRNA between HSC and damaged cells and (iv) 
presence of pluripotent stem cell population in the bone marrow in addition to HSC & 
MSC that may contribute to regeneration. Presence of other stem cells in the BM may also 
explain the loss of contribution of BM cells to organ regeneration with the use of highly 
purified population of HSC [16]. Of these various possibilities (i) and (ii) are extremely rare 
and most likely the fact that BM houses heterogeneous and perhaps pluripotent stem cells 
may explain transdifferentiation potential of bone marrow. It has been demonstrated that 
there are heterogeneous stem cell populations in adult bone marrow compartment. Under 
appropriate experimental conditions, a certain type of bone marrow stem cells appears to 
differentiate (or transdifferentiate) into a variety of non-haemopoietic cells of ectodermal, 
mesodermal and endodermal origins (such as myocytes, neural cells and hepatocytes) 
[67].Various investigators have reported pluripotent stem cells in the bone marrow by using 
varied approaches to demonstrate their presence and are listed in Table 1. 
The potential relationship of the BM-derived pluripotent stem cells reported by various 
investigators and compiled in Table1 is not clear. It is possible that these are overlapping 
populations of cells identified by slightly different isolation/ expansion strategies and likely 
that all of these versatile BM-derived Oct-4+ non-hematopoietic stem cells, which were 
given different names, are in fact very closely related to the same type of BM-residing 
Pluripotent Stem Cells (PSC). This overlap was elegantly described earlier by Ratajczak and 
his group [25] that various investigators are looking from different "keyholes" at the same 
population of stem cells that are hiding in a "darkroom" of the bone marrow environment. 
They further suggested that a ‘founder cell’ may exist in the bone marrow which is 
responsible for multi-lineage differentiation. Table 2 is a compilation of various markers 
reported on these differently described PSCs in the bone marrow responsible for their 
mobility (CXCR4), pluripotency (Oct-4, Nanog, Rex, Tert), non-hematopoietic lineage 
(CD45), immune status (MHC-1) and their developmental migration similarity to PGCs 
(SSEA1).  
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Stem Cell Functional attributes (in brief) 
MAPCs 
Multipotent 
Adult 
Progenitor 
Cells 
Described first by Verfailles and her group [19] 
Extracted from bone marrow in mouse, rat and human 
Plastic in nature and give rise to multiple cell types 
Single MAPC in early mouse embryo can contribute to all body tissues 
Ability to transdifferentiate 
Do not form teratomas 
SSEA-1+, CD13+, Flk-1low, Thy-1low, CD34–, CD44–, CD45–, CD117(c-kit)–, 
MHC I–, MHC II–m SSEA1+, OCT-4+ 
Can reconstitute bone marrow and also give rise to HSCs 
Many characteristics like ES cells 
MAPCs maintain telomere length  
Pluripotent properties even after 50 doublings 
MIAMI 
Marrow 
Isolated Adult 
Lineage 
Inducible Cells 
Bone marrow derived adult stem cells isolated in humans aged 3- 72 years [20] 
Pluripotent by nature 
Capable of differentiating into cells from all three germ layers 
Positive for OCT-4, REX-1 and telomerase 
>50 population doublings with no sign of senescence 
Express markers typically associated with embryonic stem cells 
RS cells 
Recycling Stem 
Cells 
Are a sub-population of cells present amongst the MSCs [21] 
Small in size 
Proliferate rapidly 
CD45- 
MACS 
Multipotent 
Adult 
Progenitor 
Cells 
Express pluripotent-state-specific transcription factors (OCT-4, Nanog and 
Rex1[22] 
Cloned from human liver, heart, and BM-isolated mononuclear cells  
High telomerase activity  
Wide range of differentiation potential. 
MPCs 
Mesodermal 
Progenitor 
Stem Cells 
Detected in bone marrow and cord blood [23] 
Exist as a sub-population in MSC culture 
Fail to divide in culture thus quiescent 
Multi- to pluripotent by nature 
Express SSEA-4, OCT-4, Nanog by IF and RT-PCR 
VSELs 
Very Small 
Embryonic-like 
Stem Cells 
Homogenous population of rare (~0.01% of BM mononuclear cells) Sca-1+ Lin– 
CD45- cells identified in murine BM [24] 
Express SSEA-1, OCT- 4, Nanog and Rex-1 & Rif-1 telomerase protein  
Small size (~3.5 μm in diameter) 
Large nucleus surrounded by a narrow rim of cytoplasm 
Open-type chromatin (euchromatin)  
Differentiate into three lineages 
Do not form teratoma 
Quiescent population of cells 
Table 1. Pluripotent Stem Cells Reported in the Bone Marrow 
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Characteristics 
Markers 
MAPC MIAMI MACS RS VSEL 
Shape and size 
Form small 
colonies in 
culture 
Form small 
colonies in 
culture 
Small Small Small 
CXCR4 + + + + + 
CD 133 ND ND - - + 
Sca 1 ND ND ND ND + 
CD 45 - - - - - 
OCT-4 + + + ND + 
REX-1 ND + + ND + 
Nanog + + + + + 
TERT + + ND + + 
SSEA 1 + ND ND ND + 
MHC-1 - ND + ND - 
Quiescent by 
nature 
No data 
available 
No data 
available 
No data 
available 
No data 
available 
+ 
Teratoma 
formation 
Do not form 
teratoma 
Do not form 
teratoma 
Do not form 
teratoma 
Do not 
form 
teratoma 
Do not 
form 
teratoma 
ND-experiment not done; + positive; - negative 
Table 2. Compilation of Various Markers on BM Pluripotent Stem Cells 
Besides these pluripotent stem cells, BM also houses Tissue Committed Stem Cells (TCSCs) 
including Epithelial Progenitor Cells (EPCs). Available literature suggests that postnatal 
neovascularization does not rely on formation of new blood vessels from pre-existing ones 
(angiogenesis) rather on EPCs migrating from the BM to induce neovascularization. EPCs 
and HSCs share certain markers like Flk-1, Tic2, Sca-1, and CD34. As a result it has been 
suggested that they both may arise from a common precursor [26].  
Interestingly the trans-differentiation ability of adult BM cells into various TCSCs like 
hepatocytes, cardiomyocytes, vascular endothelial cells, neuronal cells etc. occurs only when 
there is a need i.e. into hepatocytes when damage is inflicted on the liver by radiation or 
chemical damage [27], into cardiomyocytes when myocardial infarction is induced [28], into 
endothelial cells on inducing ischemia [29] and into neural stem cells on inducing stroke 
[30]. In the same manner, the BM stem cells have also been shown to trans-differentiate into 
germ cells when gonadal function is compromised e.g. by treating with busulphan in female 
[31] and male [32] mice. Freshly prepared BM may also exhibit early tissue-specific markers 
but are up-regulated several folds when the function of organ is compromised [33].  
Pluripotent stem cells are expected to be more primitive to TCSCs based on their 
developmental hierarchy (totipotent - pluripotent - multipotent– unipotent stem cells). This 
is also supported by various observations shown below.  
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 Freshly isolated TCSC from the BM express tissue committed markers 
 PSCs in BM acquire these markers after many days in culture 
 TCSCs express c-Kit which is a more differentiated marker not expressed by PSCs. 
Thus we propose following developmental hierarchy of stem cells in bone marrow (Figure:2) 
as opposed to the existing notion that HSC sit at the apex of hematopoietic system [1]. 
 
Figure 2. Developmental hierarchy of stem cells in bone marrow 
The existing controversial literature that HSCs and MSCs can trans-differentiate into various 
lineages can be alternatively explained by the presence of these pluripotent stem cells. These 
PSCs interact closely with the MSCs by a process defined as emperipolesis [34]. The MSCs 
secrete SDF-1(Stromal Derived Factor-1) and other chemo-attractants thereby creating a 
homing environment for these pluripotent stem cells (express CXCR4). Thus isolated BM 
stem cells have always been contaminated with these PSCs which may have resulted in 
trans-differentiation and that HSCs/MSCs (being lineage restricted themselves) possibly do 
not account for the observed plasticity.  
3. Origin & deposition of hematopoietic and non-hematopoietic stem 
cells in bone marrow 
Early embryogenesis is the most active period for the developmental migration/trafficking 
of stem cells. With the beginning of gastrulation and organogenesis, stem cells migrate to 
places where they establish rudiments for new tissues and organs. At certain points, of 
development stem cells colonize tissue specific niches, where they reside as a population of 
self renewing cells supplying new cells that effectively replace senescent ones or those 
undergoing apoptosis. 
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In mammals the first primitive HSC are found in the yolk sac and first definitive HSC a few 
days later in the aorta-gonadmesonephros (AGM) region [35]. From the yolk sac and/or 
AGM region HSC migrate to the fetal liver (FL), which during the second trimester of 
gestation becomes the major mammalian hematopoietic organ. By the end of the second 
trimester of gestation, HSC leave the fetal liver and colonize BM tissue. Signals for the 
translocation of HSC from the fetal liver to BM are provided by the alpha chemokine – SDF-
1 that is secreted by osteoblasts lining the developing marrow cavities, marrow fibroblasts 
and endothelial cells. In response to SDF-1, HSC that expresses, SDF-1 receptor-a seven 
transmembrane-spanning G protein coupled CXCR4 receptor, leave the fetal liver and begin 
to home into BM where they finally establish adult haematopoiesis. 
It is very likely that at this point BM is also colonized by several other nonhematopoietic 
stem cells that may circulate during organogenesis and rapid foetal growth/expansion. In 
support of this stem cells for different tissues express CXCR4 on their surface and follow an 
SDF-1 gradient. Thus the SDF-1-CXCR4 axis alone or in combination with other 
chemoattractants plays a crucial role in the accumulation of non-hematopoietic stem cells in 
developing BM [36, 37]. These cells find a permissive environment to survive in BM, and 
may play an underappreciated role as a reserve pool of stem cells for organ/tissue 
regeneration during postnatal life. 
The presence of these various populations of stem cells in the BM (Table 1) is a result of the 
‘developmental migration’ of stem cells during ontogenesis and the presence of the 
permissive environment that attracts them to the BM tissue. HSC and other non-
hematopoietic stem cells are actively chemoattracted by factors secreted by BM stromal cells 
and osteoblasts (e.g. SDF-1), hepatocyte growth factor (HGF)) and colonize marrow by the 
end of the second and the beginning of the third trimester of gestation [24].  
It is assumed that these non-hematopoietic pluripotent stem cells are deposited in the BM 
during early embryogenesis and subsequently may be mobilized in stressed situations and 
circulate in the peripheral blood. Similarly due to the stress of delivery these cells may also 
be present in cord blood [18]. 
Interestingly various terminologies like MAPCs, MIAMI, RS cells etc. (Table 1) disappeared 
from the literature after initial publications and excitement except VSELs. Ratajczak and 
group have made tremendous contribution to the field of VSELs biology. At present various 
laboratories across the world are providing evidence to support the pluripotent property 
and potential of VSELs isolated from cord blood and bone marrow [38]. Possible reason 
being the method to isolate VSELs by flow cytometry described by Ratajczak and group 
could easily be replicated in various labs across the world.  
4. Very small embryonic like stem cells (VSELs) 
VSELs were identified by Ratajczak and group in 2006 by multi parameter sorting in adult 
murine BM. They express several morphological (e.g., relatively large nuclei containing 
euchromatin) and molecular (e.g. expression of SSEA-1, Oct4, Nanog, Rex1) markers 
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characteristic for embryonic stem cells (ESCs) [33]. The morphology of the cells was 
investigated using transmission electron microscopy which showed their distinctive 
morphology and size differentiating VSELs from HSC in particular in terms of size (3–6 μm vs. 
6–8 μm for HSC), chromatin structure and nucleus/cytoplasm ratio. Based on their small size, 
presence of PSC markers, distinct morphology (open-type chromatin, large nucleus, narrow rim 
of cytoplasm with multiple mitochondria) and ability to differentiate into all three germ layers, 
including mesoderm-derived cardiomyocytes, these cells were named very small embryonic-
like stem cells. The true expression of Oct-4 and Nanog in BM-derived VSELs (BM-VSELs) was 
recently confirmed by demonstrating transcriptionally active chromatin structures of Oct4 and 
Nanog promoters. A mechanism based on parent-of-origin-specific reprogramming of genomic 
imprinting that keeps VSELs quiescent in a dormant state in tissues has been described. VSELs 
highly express Gbx2, Fgf5, and Nodal, but express less Rex1/Zfp42 transcript as compared to 
ESC-D3s what suggests that VSELs are more differentiated than ICM-derived ESCs and share 
several markers with more differentiated EpiSCs. VSELs also highly express Dppa2, Dppa4, 
and Mvh, which characterize late migratory PGCs. The expression of germ line markers (Oct4 
and SSEA-1) and modulation of somatic imprints suggest a potential developmental similarity 
between VSELs and germ line-derived primordial germ cells (PGCs) [39, 40].  
Developmental Origin of VSELs: VSELs are epiblast-derived PSCs deposited early during 
embryonic development in developing organs as a potential reserve pool of precursors for 
TCSCs and thus this population has an important role in tissue rejuvenation and 
regeneration. VSELs originate from or are closely related to a population of proximal 
epiblast migratory Stem Cells (EpiSCs) that approximately at embryonic day (E)7.25 in mice, 
become specified to PGCs, and egress from the epiblast into extra-embryonic tissues (extra-
embryonic mesoderm) [41]. VSELs follow developmental route of HSCs colonizing together 
with HSCs first fetal liver and subsequently BM [37]. 
Thus PGCs, HSCs, and VSELs form all together a unique highly migratory population of 
interrelated Stem Cells (SCs) that could be envisioned to be a kind of ‘‘fourth highly 
migratory germ layer.’’ [37] 
Self-renewal and in vitro differentiation of VSELs: VSELs exist in various mouse organs [42], 
have been well-characterized and are capable of differentiating into all three lineages, 
supporting their true pluripotent character. Murine VSELs form embryoid body-like 
structures in co-cultures over C2C12 supportive cell line [24] and could become specified 
into HSCs after co-culture over OP-9 stroma cells. VSELs-derived HSCs harvested from 
these co-cultures reconstitute murine bone marrow after total body irradiation [43]. The 
Umbilical Cord Blood (UCB)-purified VSELs have also been reported to differentiate into 
neural cells [44] and after co-culture over OP-9 stroma cells were specified into HSCs similar 
to murine BM-derived VSELs [45]. Apart from umbilical cord blood and bone marrow, 
VSELs have also been reported in Wharton’s jelly and gonadal tissue [46- 51]. Their presence 
amongst the MSCs in the Wharton’s jelly is in agreement with observations made by other 
groups that MSCs contain a sub-population of more primitive stem cells [52] or even as 
postulated by Taichman and group [53] that VSELs are precursors of MSCs. Various studies 
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have also reported that VSELs are mobilized into peripheral blood in response to injury/ 
stress in animal models [27,54-56] as well as in humans [28-30,57] – thus suggesting a role in 
regeneration and homeostasis.  
5. Our studies on VSELs in cord blood and bone marrow 
We studied the VSELs in UCB and discarded fraction of BM [46]. Usually the ‘buffy coat’ 
obtained after Ficoll-Hypaque centrifugation is considered to be rich in stem cells and used 
for various studies over several decades. However, we reported that VSELs settle along 
with the RBCs rather than getting enriched in the ‘buffy coat (Figure:3). Similarly we 
found that the ‘discarded’ RBC pellet obtained during initial processing of bone marrow 
was also rich in VSELs. These results were explained on the basis of buoyancy. The adult 
stem cells have abundant cytoplasm, are relatively larger and thus observed in the buffy 
layer whereas the VSELs are the pluripotent stem cells, with high nucleo-cytoplasmic 
ratio, minimal cytoplasm and thus sink to the bottom of the tube along with the RBCs. 
These VSELs exhibited various pluripotent markers, like CD45-, CD133+ SSEA-4+. They also 
exhibit other primordial germ cell markers like Stella and Fragillis, thus supporting their 
origin from the epiblast stage embryo at the same time when PGCs migrate via the dorsal 
mesentry to the gonadal ridges to become a source of germ cells.  
 
Figure 3. Isolation and characterization of VSELs from Cord Blood: A-Separation of cord blood into 
four layers on Ficoll-Hypaque; B-Description of cells observed in each layer separated; C-
Immunolocalization studies on MNC (A) and VSEL (B) using polyclonal Oct-4 (40X); D-Markers 
characterized on VSELs using Quantitative PCR and immunofluorescence 
These studies have several implications e.g. the stem cell biologists should ask themselves 
what is getting banked in the cord blood banks. VSELs unknowingly get discarded and only 
adult stem cells (and progenitors) including HSCs and MSCs get banked. Similarly autologus 
stem cell therapy for various indications other than blood related diseases have resulted in 
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minimal improvement. This may be explained since fate restricted progenitors HSC and MSC 
may have limited trans-differentiation ability. The pluripotent VSELs have maximum 
‘plasticity’ and regenerative potential but are getting discarded unknowingly. This raises a 
valid question on the success of BM transplantation to treat blood related diseases. This 
success could be accounted for by the differentiation ability of progenitor cells into blood cells. 
While doing immunolocalization studies to detect OCT-4 positive cells, we found the VSELs 
express nuclear OCT-4 whereas a slightly bigger cell in the ‘buffy coat’ collected from both 
the cord blood and bone marrow exhibited cytoplasmic OCT-4 (Figure:4). These are possibly 
the most immediate progenitors ‘descendants’ from VSELs. We also conducted 
immunolocalization studies on umbilical cord tissue in the region of Wharton’s jelly which 
is rich in MSCs. Results show that the MSCs had cytoplasmic OCT-4 like HSCs and that 
there was a distinct subpopulation of small cells with nuclear OCT-4 and were the VSELs, 
based on their size (Figure:4). On a similar note, when we did immunolocalization of mouse 
bone marrow stem cells, we observed that the MSCs with typical fibroblast like morphology 
have cytoplasmic OCT-4 along with VSELs with nuclear OCT-4. The MSCs showed a very 
heterogeneous staining pattern. Only a sub population of MSCs were positive whereas other 
MSCs totally lacked cytoplasmic OCT-4. This possibly shows different differentiation state 
since as the cell gets more committed, cytoplasmic OCT-4 is no longer required. 
 
Figure 4. Immunolocalization of Oct-4 in umbillical cord tissue 
Thus we concluded that the bone marrow compartment comprises of pluripotent VSELs and 
their immediate descendants like HSCs and MSCs. Also that the most primitive stem cell in 
the bone marrow is a pluripotent VSEL as shown in Figure 2. Being the most primitive stem 
cell in the BM, we hypothesize that VSEL will show best engraftment post transplantation 
and also will be best vehicle for gene therapy.  
VSELs possibly undergo asymmetric cell division to self- renew and give rise to progenitors 
which further expand and differentiate to committed cell types. VSELs remain relatively 
quiescent throughout life, maintain long telomeres and are possibly the normal body stem 
cells which give rise to cancer stem cells (CSC) under certain unfavourable conditions. We 
propose that this transformation of a VSEL into CSC occurs due unidentified changes in the 
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microenvironment. Recently it has also been reported that VSELs resist radiotherapy (because 
of their quiescent nature) that destroys all actively dividing stem cell population in the bone 
marrow [43]. The somatic microenvironment is also compromised by the radiotherapy. Thus 
although the VSELs persist, they are unable to reconstitute the bone marrow. 
Existence of two stem cell populations in various adult body tissues is an interesting concept 
put forth by Li and Clevers [58]. They proposed that both quiescent (out of cell cycle and in 
a lower metabolic state) and active (in cell cycle and not able to retain DNA labels) stem cell 
subpopulations may coexist in several tissues like gut epithelium, hair follicle, bone marrow 
etc. We have generated data to show that similar two distinct populations of stem cells exist 
in mammalian gonads also. Interestingly similar stem cell biology persists in the mammalian 
gonads irrespective of sex and is possibly an evolutionarily conserved phenomenon as we 
have reported the same in mice, rabbits, sheep, monkey and humans [48, 50]. 
6. VSELs in mammalian testis 
We have reported for the first time the presence of a distinct population of VSELs with 
nuclear OCT-4 in adult mouse [48] and human [47] testis, located towards the basement 
membrane of the seminiferous tubules. Besides, we also detected a progenitor stem cell 
population with cytoplasmic OCT-4, which was slightly bigger and had abundant 
cytoplasm. These cells showed extensive proliferation with cytoplasmic bridges as cords. As 
these cells differentiated further, the cytoplasmic OCT-4 was gradually lost. Interestingly the 
VSELs were found resistant to busulphan treatment which otherwise destroyed the dividing 
progenitors, haploid cells and damaged the somatic niche. Thus, it is evident that like the 
earlier report on bone marrow VSELs, gonadal VSELs are also resistant to oncotherapy. 
VSELs possibly undergo asymmetric cell division to give rise to progenitors, which undergo 
clonal expansion and may further differentiate into sperm (Figure:5) 
7. VSELs in mammalian ovary 
A gentle scraping of the adult ovary surface (mouse, rabbit, sheep, monkey and human) 
with a sterile blade releases stem cells in a Petri dish [50]. On H & E staining, two distinct 
stem cell populations can be easily detected based on their size and differential OCT-4 
staining pattern. The smaller stem cell population are smaller than the RBCs and exhibit 
nuclear OCT-4 whereas the slightly bigger population exhibits cytoplasmic OCT-4. Like 
cords in the testis, in the ovary we observed the presence of germ cell nests with cytoplasmic 
continuity representing extensive proliferation of progenitor stem cells. These stem cells 
were present in peri- menopausal human ovary and also persisted in mouse ovary after 
busulphan treatment. Like in the testis, the functionality of ovarian stem cells is also affected 
by a compromised niche. 
Three weeks culture of peri-menopausal ovarian stem cells produces oocyte-like structures, 
embryo-like structures in vitro [50]. Thus the stem cells retain their functionality but are 
unable to differentiate because of a non-supportive niche.  
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Figure 5. Revised scheme for premeiotic development of germ cells in adult human testis 
8. Significance of somatic microenvironment ‘Niche’ on VSELs 
functionality 
A relatively quiescent VSEL and actively dividing progenitor model that possibly exists in 
ovary, testis, bone marrow, cord blood and Wharton’s jelly ensures that the ‘master stem 
cell’ undergoes very few rounds of DNA replication to prevent its genome from age-related 
changes and acquisition of errors during DNA replication. 
Table 3 highlights the importance of the somatic niche in controlling the stem cell fate. It is 
the same VSEL that exists in different body organs but the niche dictates its fate [46]. 
 
Sr.no Tissue VSEL with 
nuclear Oct-4 
Progenitor stem cells with cytoplasmic Oct-4 
(tissue-specific progenitor stem cells) 
1 Testis   Adark spermatogonia stem cells SSCs (Adark) 
2 Ovary  Ovarian germ stem cells (OGSCs) 
3 Bone marrow,  
Umbilical cord 
blood and tissue  
 Hematopoietic stem cells (HSC) 
Mesenchymal stem cells (MSC) 
 
Table 3. Details of Very Small Embryonic-Like Stem Cell–Derived Progenitors in Adult Human Tissues 
The possible reason why extensive plasticity of VSELs is evident in bone marrow and cord 
blood (so many different kind of TCSCs have been described) in contrast to testis or ovary 
may be because the bone marrow niche is more permissive as compared to a ‘gonadal’ niche 
which is more specialized and thus restricted in nature. 
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9. VSELs and cancer 
Several years of cancer research suggests that cancers begin with genetic changes that occur 
over a period of 15 to 20 years and in few cases a link to chronic inflammation has been 
proposed e.g. in case of ovarian cancers, Barrett’s esophagus etc. However, emerging literature 
suggests that quiescent VSELs distributed in various organs may be a cellular origin of cancer 
development. In 1855 Virchow proposed the embryonal rest hypothesis of tumor formation, 
based on histological similarities between tumors and embryonic tissues. This theory was later 
expanded by other pathologist including Julius Conheim, who suggested that tumors develop 
from residual embryonic remnants lost during developmental organogenesis [59] 
Recently identified VSELs in various adult body tissues display morphology and markers 
characteristics as the pluripotent embryonic stem cells. These cells could support Virchow’s 
concept of an embryonic origin of cancer. Possibly the somatic niche, which keeps the VSELs 
in a quiescent stage under normal circumstances, undergoes some changes which push the 
quiescent VSELs to an actively dividing state i.e. the tumor.  
Wang et al [60] recently reported that persisting embryonic cells in adult mice and humans at 
the squamo-columnar junction are possibly the source of Barrett's metaplasia and that it does 
not arise from mutant cells. They proposed that certain precancerous lesions, such as 
Barrett's, initiate not from genetic alterations but from competitive interactions between cell 
lineages driven by opportunity. Similarly, almost 90% of ovarian cancers arise from the ovary 
surface epithelium which is also the niche for ovarian stem cells. It is being proposed that 
ovarian niche gets compromised with age leading to menopause [61, 62] and also to cancer. It 
is essential to dissect out age related changes which lead to menopause and how they differ 
from those which lead to cancer. OCT-4, characteristic marker of VSELs is also a very good 
marker with high sensitivity and specificity for testicular germ cell tumors as well [63]. 
Cancer stem cells and VSELs with embryonic characteristics have a lot of similarities in 
terms of markers, telomere length, and resistance to radiotherapy; thus it may be proposed 
that VSELs transform into CSCs when certain not so well understood changes occur in the 
microenvironment. It is possible that inflammation may alter the niche where the VSELs 
reside. It is highly unlikely that a somatic cell which is relatively senescent and has short 
telomeres will dedifferentiate and acquire long telomeres to transform into a cancer stem 
cell. Keeping this in mind, because of a defect in stem cell in the bone marrow due to an 
altered niche – defective stem cell divisions occur and differentiation of such altered cells 
results in appearance of chromosomal defects in mononuclear cells picked by standard 
cytogenetic studies.  
Identification of VSELs in adult tissues also opens new areas of investigation to elucidate 
how these cells contribute to the development of poorly differentiated tumors. Studying the 
biology of normal stem cells may help us to better understand the biology of cancer, and 
explain its resistance to radio-chemotherapy, ability to an unlimited proliferation and 
establishment of distant metastases.  
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10. Conclusions 
The field of BMT also stands to greatly benefit once VSELs potential are realized. A review 
article by Takizawa et al [64] makes an interesting reading and that despite advances in the 
field, timely availability of HLA matched BM is still problematic for patients including those 
who require multiple transplantations. In this context, in vitro expansion of HSC is crucial 
but not yet achieved. It is still hoped that a single HSC may suffice to induce long-term 
multilineage engraftment. Notta et al [65] reported the possibility of CD49f as a specific 
marker to isolate HSC. In the chapter we are proposing that VSELs possibly give rise to HSC 
and may be better cell source to induce engraftment. Using cell surface markers to identify 
cell types always has associated issues since surface phenotype of a cell can change 
depending on the activation status of the precursor cells. Danova-Alt et al [66] recently 
concluded that UCB VSELs neither have embryonic nor adult stem cell-like phenotype, are 
not equivalent to mouse VSELs, have aneuploid karyotype and should not be regarded as a 
stem cell population. However, they have studied Lin-/CD45-/CD34+ cells and not Lin-
/CD45-/CD133+ cells, which are the VSELs as described by Ratacjzak and group [38]. Further 
it remains to be confirmed whether the aneuploidies they report are a technical artefact, 
since no cell lineage is expected to be aneuploid.  
VSELs could potentially be a real therapeutic alternative to the use of human ES cells since 
they do not form teratomas, are relatively quiescent and can be isolated from an autologous 
source. The fact that VSELs may differentiate in vitro into cells from all three germ layers 
makes these cells potential candidates in regenerative medicine. Finally, the mechanism by 
which VSELs could contribute to development of some malignancies could shed more light 
on origin of tumours. In conclusion it is of vital importance to evaluate if VSELs could be 
efficiently employed in the clinic. The work on VSELs is on the verge of development and in 
coming years will bring more answers to the potential of these cells. 
11. Key points of the Chapter 
 The trans-differentiation potential of the HSC or MSC from bone marrow is 
controversial and can be alternatively explained by the presence of pluripotent stem 
cells in the bone marrow. 
 MAPC, MIAMI, VSELs, RS are possibly the same pluripotent stem cells, described 
differently by various investigators. All of these terminologies have disappeared over 
time in published literature except VSELs that are being widely studied by various 
groups across the world. 
 VSELs are epiblast derived stem cells expressing pluripotent markers with high nucleo-
cytoplasmic ratio and transcriptionally active chromatin. They have been isolated from 
various murine organs as well as from human organs including gonadal tissues, cord 
blood, bone marrow and Wharton’s jelly. 
 VSELs (with nuclear OCT-4) possibly are the most primitive cell type in BM and 
umbilical cord and give rise to HSC and MSC (with cytoplasmic OCT-4).  
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 The quiescent nature of VSEL prevent it from tumor formation in vivo but an altered 
somatic niche may lead to transformation of VSEL to cancer stem cell – resulting in 
cancer. 
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